An information platform on cancer immunotherapies and immuno-oncology treatments for cancer patients across Europe. The IOP aims to provide patients with all forms of cancer and their caregivers with up-to-date, accessible information about cancer immunotherapy – treatments with use the immune system to fight cancer.
ECPC is establishing a Bladder Cancer Working Group to guarantee that bladder cancer patients and patient organisations will be able to contribute to our bladder cancer activities. Click here and join our Bladder Cancer Working Group!
Patient Preferences in Benefit-Risk Assessments during the Drug Life Cycle (PREFER) is a five-year project funded by the European Commission's Innovative Medicines Initiative (IMI) 2 programme to evaluate different ways of assessing clinical patient preferences.
TeamECPC is a group of committed athletes, runners, friends and colleagues who support ECPC by participating on our behalf to competitive and non-competitive sports events. Join our team of runners!